Initial Results of the Mitral Valve Repair Clinical Trial (MAVERIC Trial) Utilizing Percutaneous Septal Sinus Shortening (The MVRx System) for the Treatment of Functional Mitral Regurgitation

Presenter: Andrejs Erglis

REGISTER for free or LOG IN to view this content

Become a GOLD or PLATINUM member to access PowerPoint files, presentation audio, and video

Initial Results of the Mitral Valve Repair Clinical Trial (MAVERIC Trial) Utilizing Percutaneous Septal Sinus Shortening (The MVRx System) for the Treatment of Functional Mitral Regurgitation

Up Next

More slides +

We Recommend